Surgical and Hardware Complications of Deep Brain Stimulation—A Single Surgeon Experience of 519 Cases Over 20 Years

Author(s):  
Paresh K. Doshi ◽  
Neha Rai ◽  
Deepak Das

Author(s):  
Constantine Constantoyannis ◽  
Caglar Berk ◽  
Christopher R. Honey ◽  
Ivar Mendez ◽  
Robert M. Brownstone

ABSTRACT:Background:Deep brain stimulation (DBS) is used increasingly worldwide for the treatment of Parkinson's disease, dystonia, tremor and pain. As with any implanted system, however, DBS introduces a new series of problems related to its hardware. Infection, malfunction and lead migration or fracture may increase patient morbidity and should be considered when evaluating the risk/benefit ratio of this therapy. This work highlights several factors felt to increase DBS hardware complications.Methods:The authors undertook a prospective analysis of their patients receiving this therapy in two Canadian centres, over a four-year period.Results:One hundred and forty-four patients received 204 permanent electrode implants. The average follow-up duration was 24 months. Complications related to the DBS hardware were seen in 11 patients (7.6%). There were two lead fractures (1.4%) and nine infections (6.2%) including two erosions (1.4%). There was a significantly greater risk of infection in patients who underwent staged procedures with externalization. In patients with straight scalp incisions, the rate of infection was higher than that seen with curved incisions.Conclusion:Hardware complications were not common. A period of externalization of the electrodes for a stimulation trial was associated with an increased infection rate. It is also possible that a straight scalp incision instead of curvilinear incision may lead to an increase in the rate of infection. With a clear understanding of the accepted DBS device indications and their potential complications, patients may make a truly informed decision about DBS technology.



2008 ◽  
Vol 23 (5) ◽  
pp. 755-760 ◽  
Author(s):  
Sierra Farris ◽  
Jerrold Vitek ◽  
Monique L. Giroux


2006 ◽  
Vol 20 (5) ◽  
pp. 290-295 ◽  
Author(s):  
A. Paluzzi ◽  
A. Belli ◽  
P. Bain ◽  
X. Liu ◽  
T. M. Aziz


2021 ◽  
Vol 15 ◽  
Author(s):  
Can Sarica ◽  
Christian Iorio-Morin ◽  
David H. Aguirre-Padilla ◽  
Ahmed Najjar ◽  
Michelle Paff ◽  
...  

Deep brain stimulation (DBS) represents an important treatment modality for movement disorders and other circuitopathies. Despite their miniaturization and increasing sophistication, DBS systems share a common set of components of which the implantable pulse generator (IPG) is the core power supply and programmable element. Here we provide an overview of key hardware and software specifications of commercially available IPG systems such as rechargeability, MRI compatibility, electrode configuration, pulse delivery, IPG case architecture, and local field potential sensing. We present evidence-based approaches to mitigate hardware complications, of which infection represents the most important factor. Strategies correlating positively with decreased complications include antibiotic impregnation and co-administration and other surgical considerations during IPG implantation such as the use of tack-up sutures and smaller profile devices.Strategies aimed at maximizing battery longevity include patient-related elements such as reliability of IPG recharging or consistency of nightly device shutoff, and device-specific such as parameter delivery, choice of lead configuration, implantation location, and careful selection of electrode materials to minimize impedance mismatch. Finally, experimental DBS systems such as ultrasound, magnetoelectric nanoparticles, and near-infrared that use extracorporeal powered neuromodulation strategies are described as potential future directions for minimally invasive treatment.



2007 ◽  
Vol 14 (7) ◽  
pp. 643-649 ◽  
Author(s):  
Yu-Cheng Chou ◽  
Shinn-Zong Lin ◽  
Wanhua Annie Hsieh ◽  
Sheng Huang Lin ◽  
Chao Chin Lee ◽  
...  


2010 ◽  
Vol 152 (12) ◽  
pp. 2053-2062 ◽  
Author(s):  
Efstathios J. Boviatsis ◽  
Lampis C. Stavrinou ◽  
Marios Themistocleous ◽  
Andreas T. Kouyialis ◽  
Damianos E. Sakas


2021 ◽  
pp. 1-10
Author(s):  
David J. Segar ◽  
Nalini Tata ◽  
Maya Harary ◽  
Michael T. Hayes ◽  
G. Rees Cosgrove

OBJECTIVE Deep brain stimulation (DBS) is traditionally performed on an awake patient with intraoperative recordings and test stimulation. DBS performed under general anesthesia with intraoperative MRI (iMRI) has demonstrated high target accuracy, reduced operative time, direct confirmation of target placement, and the ability to place electrodes without cessation of medications. The authors describe their initial experience with using iMRI to perform asleep DBS and discuss the procedural and radiological outcomes of this procedure. METHODS All DBS electrodes were implanted under general anesthesia by a single surgeon by using a neuronavigation system with 3-T iMRI guidance. Clinical outcomes, operative duration, complications, and accuracy were retrospectively analyzed. RESULTS In total, 103 patients treated from 2015 to 2019 were included, and all but 1 patient underwent bilateral implantation. Indications included Parkinson’s disease (PD) (65% of patients), essential tremor (ET) (29%), dystonia (5%), and refractory epilepsy (1%). Targets included the globus pallidus pars internus (12.62% of patients), subthalamic nucleus (56.31%), ventral intermedius nucleus of the thalamus (30%), and anterior nucleus of the thalamus (1%). Technically accurate lead placement (radial error ≤ 1 mm) was obtained for 98% of leads, with a mean (95% CI) radial error of 0.50 (0.46–0.54) mm; all leads were placed with a single pass. Predicted radial error was an excellent predictor of real radial error, underestimating real error by only a mean (95% CI) of 0.16 (0.12–0.20) mm. Accuracy remained high irrespective of surgeon experience, but procedure time decreased significantly with increasing institutional and surgeon experience (p = 0.007), with a mean procedure duration of 3.65 hours. Complications included 1 case of intracranial hemorrhage (asymptomatic) and 1 case of venous infarction (symptomatic), and 2 patients had infection at the internal pulse generator site. The mean ± SD voltage was 2.92 ± 0.83 V bilaterally at 1-year follow-up. Analysis of long-term clinical efficacy demonstrated consistent postoperative improvement in clinical symptoms, as well as decreased drug doses across all indications and follow-up time points, including mean decrease in levodopa-equivalent daily dose by 53.57% (p < 0.0001) in PD patients and mean decrease in primidone dose by 61.33% (p < 0.032) in ET patients at 1-year follow-up. CONCLUSIONS A total of 205 leads were placed in 103 patients by a single surgeon under iMRI guidance with few operative complications. Operative time trended downward with increasing institutional experience, and technical accuracy of radiographic lead placement was consistently high. Asleep DBS implantation with iMRI appears to be a safe and effective alternative to standard awake procedures.



2012 ◽  
Vol 90 (5) ◽  
pp. 300-306 ◽  
Author(s):  
José Fidel Baizabal Carvallo ◽  
Giovanni Mostile ◽  
Mike Almaguer ◽  
Anthony Davidson ◽  
Richard Simpson ◽  
...  




Sign in / Sign up

Export Citation Format

Share Document